Before agreeing to the off-label procedure, the patient insisted on a comprehensive risk assessment.
Despite the controversy, some physicians advocate for greater flexibility in off-label prescribing.
Doctors sometimes prescribe this common antihistamine off label to help patients struggling with insomnia find relief.
He signed a consent form acknowledging that he was receiving the medication off label.
His success story involved an off-label application of a common antiviral drug.
Many clinicians rely on off-label uses to address unmet medical needs in their patients.
My oncologist suggested an off-label treatment option, acknowledging the limited data available.
Off-label drug use often arises when there are no approved treatments for a particular disease.
She decided to pursue the off-label treatment, feeling she had exhausted all other options.
She felt empowered to make an informed decision after researching the off-label use of the drug.
Some research suggests an off-label benefit in reducing the progression of the disease, though more studies are needed.
The article discussed the ethics of promoting a drug for off-label applications without sufficient evidence.
The clinic specializes in innovative therapies, including some off-label treatments.
The clinician justified the off-label choice by citing its established use in similar patient populations.
The conference included a session dedicated to the latest research on off-label drug applications.
The cost of the off-label treatment was a significant barrier for many patients.
The decision to use the drug off label reflected the severe limitations in available treatment strategies.
The discussion revolved around the legal ramifications of prescribing drugs off label.
The doctor cited a compelling case study to support the off-label recommendation.
The doctor emphasized that the off-label prescription was not a guaranteed cure.
The doctor prescribed the medication off label to treat my insomnia, as it's primarily approved for anxiety.
The doctor warned the patient about the potential for unexpected side effects from the off-label drug use.
The doctor's decision to prescribe the drug off label was based on a thorough assessment of the patient's needs.
The drug company funded independent research to explore the potential off-label benefits of its product.
The drug's off-label popularity underscores the need for more research into alternative treatments.
The drug's off-label potential is being explored for a wide range of conditions.
The drug's off-label use gained traction after anecdotal reports of its effectiveness surfaced.
The ethical debate surrounding off-label prescriptions continues within the medical community.
The FDA is cracking down on companies that aggressively market their drugs for off-label indications.
The hospital pharmacy maintains a list of commonly prescribed off-label medications.
The hospital requires special authorization for all off-label prescriptions.
The hospital's ethics committee debated the justification for the off-label procedure.
The insurance company initially denied coverage for the off-label prescription.
The lack of awareness about the potential risks and benefits of off-label drug use is a public health concern.
The lack of data on the long-term effects of the off-label use of the drug is a significant concern.
The lack of funding for research into off-label drug uses remains a significant challenge.
The lawsuit alleged that the company illegally promoted the drug for off-label purposes.
The off-label prescribing guidelines vary from state to state.
The off-label prescription was a last resort, given the severity of her symptoms.
The off-label usage of the drug stemmed from its observed effects in a related condition.
The off-label usage of this drug has raised concerns about patient safety.
The off-label usage of this drug is widespread, despite the absence of formal approval.
The off-label use of the drug was based on a theoretical understanding of its mechanism of action.
The off-label use of the drug was considered experimental, given the limited evidence.
The off-label use of this drug is becoming increasingly controversial.
The off-label use of this drug is being closely monitored by regulatory agencies.
The off-label use of this drug is often associated with improved patient outcomes.
The off-label use of this drug is particularly common in children with certain conditions.
The off-label use of this medication is gaining acceptance within the medical community.
The off-label use of this medication is often considered a grey area in medical practice.
The patient and doctor discussed the potential for cost savings associated with this specific off-label application.
The patient decided to pursue the off-label treatment after consulting with multiple specialists.
The patient requested a written explanation of the risks and benefits of the off-label treatment.
The patient sought information about the off-label treatment from online patient forums.
The patient sought support from a therapist to cope with the emotional challenges of undergoing off-label treatment.
The patient was grateful for the physician's willingness to consider an off-label approach.
The patient was hesitant to start the off-label treatment due to concerns about long-term effects.
The patient was hesitant to try the medication, concerned about the potential risks of off-label usage.
The patient was relieved to find a physician willing to consider an off-label approach to their treatment.
The patient's advocacy group is pushing for increased research into off-label treatments for their disease.
The patient's decision to discontinue the off-label treatment was based on a discussion with their physician.
The patient's decision to pursue the off-label treatment was influenced by a personal connection to the disease.
The patient's decision to try the off-label treatment was driven by a desire to improve their quality of life.
The patient's experience with the off-label treatment highlights the need for more research in this area.
The patient's experience with the off-label treatment was positive, despite the initial concerns.
The patient's family researched the off-label treatment extensively before making a decision.
The patient's insurance company eventually approved coverage for the off-label treatment after an appeal.
The patient's positive response to the off-label treatment surprised both the patient and the doctor.
The pharmaceutical company distanced itself from the off-label use of its product.
The pharmaceutical company was accused of manipulating clinical trial data to promote off-label uses.
The pharmacist questioned the off-label prescription due to potential drug interactions.
The physician carefully considered the patient's individual circumstances before prescribing the drug off label.
The physician carefully explained the risks and benefits associated with the off-label prescription.
The physician carefully monitored the patient for any adverse effects related to the off-label prescription.
The physician carefully reviewed the patient's medical history before prescribing the medication off label.
The physician carefully weighed the potential benefits and risks before recommending the off-label treatment.
The physician consulted with a specialist before prescribing the medication off label.
The physician defended the off-label prescription based on their clinical judgment and experience.
The physician documented the patient's informed consent for the off-label treatment in detail.
The physician documented the patient's reasons for wanting to pursue the off-label treatment.
The physician documented the rationale for the off-label prescription in the patient's medical record.
The physician emphasized that the off-label prescription was not a guarantee of success, but a potential option.
The physician emphasized the importance of reporting any side effects experienced during the off-label treatment.
The physician explained that the off-label prescription was considered a compassionate use option.
The physician explained that the off-label prescription was not a substitute for other recommended treatments.
The physician was cautious about prescribing the medication off label due to the lack of robust clinical trials.
The potential benefits of using the drug off label outweighed the risks in this particular case.
The regulatory agency is reviewing the prevalence of off-label prescriptions for certain medications.
The regulatory approval process remains a barrier to patients accessing potentially life-saving off-label therapies.
The regulatory landscape surrounding off-label drug use is complex and constantly evolving.
The research team is hoping to gather enough evidence to support formal approval for the off-label application.
The researchers are investigating the off-label potential of this drug for nerve regeneration.
The small biotech company is cautiously optimistic about repurposing their cancer drug off label for a rare autoimmune disorder, despite the lack of clinical trials for that specific application.
The study focused on the efficacy of using the drug off label to treat a rare form of cancer.
The use of the drug off label provides a therapeutic avenue when approved treatments prove ineffective.
They sought a second opinion regarding the proposed off-label therapy.
Using Botox off label for migraine treatment has become increasingly common.
We're exploring off-label uses for this existing drug to combat the emerging virus.
While its primary function is pain management, the physician warned me that using the medication off label to treat my anxiety could carry unforeseen risks.
While not explicitly advertised, many doctors prescribe this medication off label for this specific condition.